Biosimilar Glargine Insulin: Implications for Prescribers and Patients
Publication
, Journal Article
Pereira, K
Published in: Journal for Nurse Practitioners
March 1, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Journal for Nurse Practitioners
DOI
ISSN
1555-4155
Publication Date
March 1, 2017
Volume
13
Issue
3
Start / End Page
236 / 237
Related Subject Headings
- Nursing
- 1110 Nursing
Citation
APA
Chicago
ICMJE
MLA
NLM
Pereira, K. (2017). Biosimilar Glargine Insulin: Implications for Prescribers and Patients. Journal for Nurse Practitioners, 13(3), 236–237. https://doi.org/10.1016/j.nurpra.2016.11.022
Pereira, K. “Biosimilar Glargine Insulin: Implications for Prescribers and Patients.” Journal for Nurse Practitioners 13, no. 3 (March 1, 2017): 236–37. https://doi.org/10.1016/j.nurpra.2016.11.022.
Pereira K. Biosimilar Glargine Insulin: Implications for Prescribers and Patients. Journal for Nurse Practitioners. 2017 Mar 1;13(3):236–7.
Pereira, K. “Biosimilar Glargine Insulin: Implications for Prescribers and Patients.” Journal for Nurse Practitioners, vol. 13, no. 3, Mar. 2017, pp. 236–37. Scopus, doi:10.1016/j.nurpra.2016.11.022.
Pereira K. Biosimilar Glargine Insulin: Implications for Prescribers and Patients. Journal for Nurse Practitioners. 2017 Mar 1;13(3):236–237.
Published In
Journal for Nurse Practitioners
DOI
ISSN
1555-4155
Publication Date
March 1, 2017
Volume
13
Issue
3
Start / End Page
236 / 237
Related Subject Headings
- Nursing
- 1110 Nursing